Octopus trial for MS treatments
The Octopus trial is being led by researchers from the Queen Square MS Centre and the Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL) and funded by the MS Society.
The multi-arm, multi-stage platform trial is designed to transform the way treatments for progressive MS are tested and will work up to three times faster than traditional trials.
More than 130,000 people live with MS in the UK and there are tens of thousands with progressive forms who have nothing to stop their MS getting worse. By tapping into the potential of approved drugs, which may have the potential to protect nerves, we can develop new treatments for MS faster.